Showing: All results
Default image

Hema Adhikari, PhD

oncoprotein signaling networks

Default image

Carmen Bergom, MD, PhD

Identification of new targets to improve tumor radiation effectiveness and to protect normal tissues such as the heart from radiation injury

Default image

Kelly L. Bolton, PhD, MD

The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis

Default image

Ron Bose, MD, PhD

Tyrosine Kinase Signaling in Breast Cancer

Default image

Jian Campian, MD, PhD

Immunotherapy, brain tumor, spinal cord tumor, high grade gliomas

Default image

Aadel A. Chaudhuri, MD, PhD

Liquid biopsy cancer detection

Default image

Feng Chen, PhD

genetic determinants and pathogenic mechanisms of urogenital diseases with the goal of improving diagnostic and therapeutic strategies targeting these diseases

Default image

Jaebok Choi, PhD

Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies

Default image

Mai Dang, PhD

neurologic complications of cancer and its treatment

Default image

Li Ding, PhD

Cancer Proteogenomics and Cancer Models

Default image

Francesca Ferraro, MD, PhD

We use both mouse models and patient samples of acute myloid leukemia to understand leukemogenesis and to identify novel therapeutic targets.

Default image

Matthew Goodwin, MD, PhD

Metabolism of cancer, targeting tumor metabolism by blocking metabolic pathways

Default image

Abby Green, MD

identify factors within DNA damage response signaling pathways that represent therapeutic vulnerabilities in order to develop new treatment options for children with cancer

Default image

Joseph Ippolito, MD, PhD

cancer, metabolism, imaging, sex differences, glioblastoma

Default image

Yoon-A Kang, PhD

Hematopoietic stem cells, Multipotent progenitor, Cell fate decision, Lineage specification

Default image

John Krais, PhD

DNA damage response and how to apply new discoveries to the treatment of cancer

Default image

Stephanie Markovina, MD, PhD

prognosis and response to radiation therapy, therapeutic targets for cervical and anal cancers

Default image

Melissa Mavers, MD, PhD

immune regulation of graft-versus-host disease (GVHD), a debilitating and potentially fatal complication of hematopoietic stem cell transplantation (HSCT)

Default image

Michael Meers, PhD

Epigenetics, Chromatin, Genomics, Gene Regulation, Cell fate, Transcription Factors

Default image

Kenneth Murphy, MD, PhD

Dendritic cells control adaptive immune responses

Default image

Hua Pan, PhD

identifying determinant protein domains governing voltage sensing and gate opening mechanisms of the cardiac IKs channel, which is a pathological determinant of the high mortality “Long QT Syndrome”

Default image

Gary Patti, PhD

To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics

Default image

Guangyong Peng, PhD

Role of Senescent T cells in tumor and neurodegeneration; tumor-associated regulatory T cells (Tregs) in suppression of anti-tumor immunity, Toll-like receptor (TLR) ligands and other immunomodulators; metabolic and epigenetic reprogramming of T cells for immunotherapy

Default image

Vikas Prasad, MD

Clinical and translational theranostics

Default image

Patrícia Ribeiro Pereira, PhD

Molecular imaging tools to understand tumor biology and response to therapies

Default image

Joshua B. Rubin, MD, PhD

tumor biology, signal transduction, stem cells, neural development, sexual dimorphism, circadaian rhythm, chemokines, cAMP

Default image

Julie Schwarz, MD, PhD

Gynecologic cancers, thyroid cancer, molecular imaging

Default image

Girdhar Sharma, PhD

Epigenetics, stem cell radiation response, chromatin and DNA damage response, apoptosis, DNA repair, post-translational histone modifications, oncogenesis.

Default image

Monica Shokeen, PhD

Antigen-4 (VLA-4) targeted PET radiopharmaceuticals, multiple myeloma, hematopoietic progenitor cells (HPCs), PET, MRI and Optical imaging techniques

Default image

Jessica Silva-Fisher, PhD

Long non-coding RNAs and RNA modifications in cancer metastasis and relapse

Default image

Priyanka Verma, Ph.D.

The Verma lab studies the causes and consequences of DNA damage in cancers

 

Default image

Zhongsheng You, PhD

Cancer, DNA damage response, RNA surveillance, cell cycle, chromatin, laser micro-irradiation, Xenopus egg extracts, imaging, genetically-encoded reporters

Default image

Mohamed Zayed, MD, PhD

mechanisms that influence arterial collateral formation and peripheral arterial atheroprogression in the setting of diabetes